Last reviewed · How we verify
NCT05156593
'Long COVID-19' in Suffolk and North Essex: Defining the Disease and Optimising Outcomes
trial in Covid19 in 355 participants. Completed in 17 June 2025.
17 June 2025
Quick facts
| Lead sponsor | East Suffolk and North Essex NHS Foundation Trust |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 355 |
| Start date | 20 August 2021 |
| Primary completion | 17 June 2025 |
| Estimated completion | 17 June 2025 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Covid19 — all drugs for Covid19 →
Sponsor
East Suffolk and North Essex NHS Foundation Trust
Who can join
18 and older, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To accurately describe the rehabilitation needs of individuals with post-COVID-19 syndrome up to 36 months after infection, allowing better diagnosis, triage and resource management. A major focus will be the impact on everyday life to return to normal activities.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05156593
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid19
Currently open trials in the same condition.
- NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
- NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
- NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
- NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting
Other East Suffolk and North Essex NHS Foundation Trust trials
Trials by the same sponsor.
- NCT05794620 — Faecal Microbiota Analysis in Neurotypical and Autism Syndrome Disorder Siblings · completed
- NCT05303870 — Impact of Psychological Therapies on Emergency Medical Patients · NA · completed
- NCT04756518 — COVID-19 Infection and Machine Learning Using Artificial Intelligence (AI) · completed
- NCT05398822 — The Role of TextRAd on Detection of Liver Metastasis in Rectal Cancer · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05156593 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by East Suffolk and North Essex NHS Foundation Trust
- Last refreshed: 6 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05156593.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing